Ontology highlight
ABSTRACT: Importance
Guidelines restricting use of calcium-based phosphate binders in all patients with end-stage renal disease owing to their potential contribution to increased cardiovascular risk shifted prescribing from calcium acetate toward the costlier sevelamer carbonate products.Objective
To compare cardiovascular events and mortality between patients with end-stage renal disease (ESRD) undergoing hemodialysis receiving sevelamer vs calcium acetate in real-world practice.Design, setting, and participants
An observational cohort study was conducted using the United States Renal Data System linked to Medicare claims data (May 1, 2012, to December 31, 2013). Data analysis was performed from October 2017 to September 2018. Participants included patients 65 years or older
SUBMITTER: Spoendlin J
PROVIDER: S-EPMC6503544 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature